Company Filing History:
Years Active: 2012
Title: Wilhelm Lubbe: Innovator in Cancer Treatment
Introduction
Wilhelm Lubbe is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of cancer research. His work primarily focuses on the inhibition of cancer cell proliferation, particularly in colorectal, gastric, and esophageal cancers.
Latest Patents
Lubbe holds a patent for the use of GCC ligands, which details a method for inhibiting the proliferation of colorectal, gastric, and esophageal cancer cells by administering an ST receptor ligand. This innovative approach involves increasing the number of ST receptor molecules on the surface of colorectal cells or metastasized colorectal cancer cells. The patent outlines pharmaceutical compositions that comprise sterile, pyrogen-free ST receptor ligands and a pharmaceutically acceptable carrier or diluent. Furthermore, it describes methods for treating or imaging metastasized colorectal cancer by targeting the ST receptor for the delivery of therapeutic or imaging agents.
Career Highlights
Wilhelm Lubbe is affiliated with Thomas Jefferson University, where he continues to advance his research in cancer treatment. His work has the potential to significantly impact the way colorectal cancer is diagnosed and treated, offering new hope for patients.
Collaborations
Lubbe has collaborated with esteemed colleagues such as Scott A. Waldman and Giovanni Mario Pitari, contributing to a rich environment of innovation and research in cancer therapies.
Conclusion
Wilhelm Lubbe's contributions to cancer research through his innovative patent demonstrate his commitment to improving treatment options for patients with colorectal cancer. His work exemplifies the vital role of inventors in advancing medical science and enhancing patient care.